Back to search

University of British Columbia

Pharmaceutical outcomes research to better understand medication non-adherence in patients with Systemic Lupus Erythematosus

Abstract

dc:description

Introduction: This thesis comprises a systematic review and a pharmacoepidemiological study aimed at improving the understanding about medication non-adherence to antimalarials (AM) in Systematic Lupus Erythematosus (SLE). AM is the conventional and effective long-term treatment option that has resulted in substantial decreases in deaths associated with SLE disease activity. However, there seems to be no such decline in the deaths associated with the sequelae of SLE (such as circulatory disease). Since deriving therapeutic effects from AM depends not only on physicians prescribing the appropriate treatment, but also on patients’ adherence with selected treatment, there is the need for a better understanding of medication non-adherence to AM in SLE. Objective: 1) To systematically review and synthesize the literature on medication adherence in SLE to identify key gaps in the literature; and 2) to evaluate the burden and determinants of medication non-adherence to AM in SLE. Methods: To address Objective 1, I have conducted a systematic review. I conducted a mapped search of Medline, Embase, and Web of Science to identify original, observational studies that indicated the data source and measurement tool to assess medication adherence in a SLE patient sample. To address Objective 2, I have conducted a longitudinal pharmacoepidemiological study of a population-based SLE cohort. I used a Cox’s proportional hazard ratio model to examine factors that were significantly associated with discontinuation of AM. Results: 1) 11 studies were included in the systematic review, and the majority of these studies reported that less than 50% of SLE patients are sufficiently adherent to their medications; 2) After five years, only 33% of patients remained on AM therapy; and 3) Higher SES and the following time-varying covariates updated monthly: glucocorticoids use, traditional NSAIDs use, rate of rheumatologist visits, and rate of dermatologists were statistically significantly protective against discontinuation of AM therapy. Conclusion: Altogether as a collective work, this thesis provides evidence that demonstrates medication non-adherence is a substantial problem in SLE. In addition, it highlights the importance of developing adherence interventions to help support patients taking their medications as prescribed.

Degree

thesis:*
Name thesis:degree_name
Master of Science - MSc
Level thesis:degree_level
master's
Discipline thesis:degree_discipline
Pharmaceutical Sciences
Grantor dc:publisher
University of British Columbia
Year dc:date
2016

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Mehat, Pavandeep

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/58570

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Mehat, Pavandeep. Pharmaceutical outcomes research to better understand medication non-adherence in patients with Systemic Lupus Erythematosus. master's thesis, University of British Columbia, 2016. http://hdl.handle.net/2429/58570